MAS
50
-10
RSG
70
-4
EFX
58
-7
MKC
63
-2
F
48
-6
SE
72
-3
HPE
10
-4
XOM
62
-2
UNM
65
-3
MCD
57
-5
KMX
60
-4
CI
59
-11
TGT
40
-4
VFC
45
-4
IP
56
-4
FITB
55
-3
UNP
29
-3
VLO
42
-4
CCL
47
-7
DIS
66
-4
MAS
50
-10
RSG
70
-4
EFX
58
-7
MKC
63
-2
F
48
-6
SE
72
-3
HPE
10
-4
XOM
62
-2
UNM
65
-3
MCD
57
-5
KMX
60
-4
CI
59
-11
TGT
40
-4
VFC
45
-4
IP
56
-4
FITB
55
-3
UNP
29
-3
VLO
42
-4
CCL
47
-7
DIS
66
-4
Financhill
Back

Akero Therapeutics Stock Predictions

Apple's Drop in iPhone Sales Opens the Door for New Entrant

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
25

AKRO
Akero Therapeutics

Last Price:
$40.55
Seasonality Move:
9.58%

7 Day Trial

ALL ACCESS PASS

$ 7

Meet the founder that's revolutionizing smartphones

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Akero Therapeutics Stock Forecast

  • Over the next 52 weeks, Akero Therapeutics has on average historically risen by 45.9% based on the past 5 years of stock performance.
  • Akero Therapeutics has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
  • Is Akero Therapeutics Stock Undervalued?
    The current Akero Therapeutics [AKRO] share price is $42.72. The Score for AKRO is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • AKRO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Akero Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Akero Therapeutics has on average historically risen by 45.9% based on the past 5 years of stock performance.

Akero Therapeutics Stock Rating

Sell
25
Akero Therapeutics (AKRO) is a Sell

Is Akero Therapeutics overpriced?

  • Akero Therapeutics has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%

Akero Therapeutics Stock Price History

Is AKRO stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
akerotx.com

52-Week Data

52-Week High:
58.40
52-Week Low:
17.86

Prediction Charts

Market Cap:
3.4B
Price in USD:
42.72
Volume:
594.2K
Beta:
-0.13

Technical Analysis

SMA50:
44.55
SMA100:
37.32
SMA200:
31.79
52-Wk Change:
69.12%

Stock Predictions

  • Is Akero Therapeutics stock public?
    Yes, Akero Therapeutics is a publicly traded company.
  • What is the Akero Therapeutics stock quote today?
    The Akero Therapeutics stock price is 42.72 USD today.
  • How to buy Akero Therapeutics stock online?
    You can buy Akero Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Mar-11 41.70 43.85 43.92 41.61
Mar-12 44.88 45.85 47.11 44.78
Mar-13 45.44 44.86 45.95 43.71
Mar-14 44.86 44.15 45.58 43.98
Mar-17 44.15 44.88 45.39 43.87
Mar-18 43.99 43.53 44.44 43.13
Mar-19 43.12 44.78 44.91 42.90
Mar-20 44.02 44.66 45.69 43.76
Mar-21 44.28 45.14 45.92 43.91
Mar-24 45.12 45.08 46.14 44.61
Mar-25 44.86 45.24 45.27 43.84
Mar-26 45.05 43.29 45.18 41.84
Mar-27 43.49 43.58 44.10 42.65
Mar-28 45.38 42.72 45.38 42.26

Akero Therapeutics Earnings

Akero Therapeutics Earnings Report: Per Share Akero Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Akero Therapeutics Forecast Revenue Growth

Akero Therapeutics Stock Analysis: Historical quarterly revenues per share for Akero Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.10 per share, and a decrease next year of $0.48 per share.

* Akero Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.